Cite
HARVARD Citation
Láinez, M. et al. (2022). Tolerability and safety of galcanezumab in patients with chronic cluster headache with up to 15 months of galcanezumab treatment. Headache. 62 (1), pp. 65-77. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Láinez, M. et al. (2022). Tolerability and safety of galcanezumab in patients with chronic cluster headache with up to 15 months of galcanezumab treatment. Headache. 62 (1), pp. 65-77. [Online].